
Liraglutide
GLP-1 for Weight Loss
Pricing confirmed during intake
Available options and package pricing are confirmed before purchase.
What is Liraglutide?
Liraglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes and now FDA-approved for chronic weight management. It works by mimicking a natural hormone that regulates appetite and blood sugar, helping you feel full sooner, eat less, and lose weight steadily — all under medical supervision through MintRx.
Quick Facts
- Form
- Subcutaneous injection
- Active Ingredient
- Liraglutide
- Dosing
- Once daily
- Avg. Weight Loss
- 5–10% body weight
Key Ingredients
Liraglutide
GLP-1 receptor agonist that slows gastric emptying, reduces appetite, and improves glycemic control — leading to sustained, clinically meaningful weight loss.
How It Works
Complete a health and weight-loss questionnaire
A licensed provider reviews your history and prescribes if appropriate
Your liraglutide injection pen is shipped discreetly to your door
Self-administer a daily subcutaneous injection with gradual dose escalation
Benefits
Clinically proven weight loss
FDA-approved for chronic weight management with average losses of 5–10% of body weight in clinical trials.
Appetite control
GLP-1 signaling helps you feel full sooner and reduces cravings, making it easier to eat less without feeling deprived.
Gradual dose escalation
Start low and increase over several weeks to minimize side effects and let your body adjust comfortably.
Metabolic benefits
Improves blood sugar regulation, reduces cardiovascular risk markers, and supports healthier metabolic function.
Medical supervision
Your MintRx provider monitors your progress, adjusts dosing, and supports you throughout your weight-loss journey.
Frequently Asked Questions
How much weight can I expect to lose?
How do I take liraglutide?
What are the common side effects?
Is it safe long-term?
Do I need to diet and exercise too?
Important Safety Information
Do not use if you or your family have a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. May cause nausea, vomiting, diarrhea, constipation, or injection site reactions. Report persistent abdominal pain (possible pancreatitis) to your provider immediately. Not for use during pregnancy or breastfeeding. Inform your provider of all medications, especially insulin or sulfonylureas.
Start your Liraglutide treatment
Complete a free consultation and get your first shipment in days.
Get Started



